Quarterly report pursuant to Section 13 or 15(d)

EQUITY (Details 2)

v3.19.3.a.u2
EQUITY (Details 2)
3 Months Ended
Nov. 30, 2019
$ / shares
shares
50,000  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of Options exercisable | shares 50,000
Weighted Average Remaining Contractual life (in years) 8 years 8 months 19 days
Weighted Average Exercise Price | $ / shares $ 10.80
Number of Shares Warrants Exercisable | shares 25,182
Warrants Exercisable Weighted Average Exercise Price | $ / shares $ 10.80
2,500  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of Options exercisable | shares 2,500
Weighted Average Remaining Contractual life (in years) 9 years 7 months 20 days
Weighted Average Exercise Price | $ / shares $ 3.12
Number of Shares Warrants Exercisable | shares 2,500
Warrants Exercisable Weighted Average Exercise Price | $ / shares $ 3.12
181,500  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of Options exercisable | shares 181,500
Weighted Average Remaining Contractual life (in years) 9 years 9 months
Weighted Average Exercise Price | $ / shares $ 1.99
Number of Shares Warrants Exercisable | shares 4,689
Warrants Exercisable Weighted Average Exercise Price | $ / shares $ 1.99